Sai Life Sciences Achieves 100% Renewable Power Status at Bidar Campus
Sai Life Sciences Limited, a leading integrated contract research, development, and manufacturing organization (CRDMO), has successfully transitioned its Bidar campus to operate entirely on renewable power. This milestone makes the Bidar site the first facility within an Indian CRDMO to achieve 100% renewable electricity usage, according to the company.The Bidar campus, which encompasses Unit IV, the company's flagship API manufacturing facility, and Unit VI, its animal health API manufacturing facility, now operates using entirely renewable sources.
The achievement reflects a commitment to long-term sustainability and resource efficiency, a viewpoint emphasized by Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences. Kanumuri stated that the infrastructure supporting medicines must anticipate a future where sustainability, resilience, and resource efficiency define global industry operations.
Renewable Energy Transition
The transition to 100% renewable power was the result of a phased, multi-year effort. The company's renewable energy sources increased significantly over time:| Year/Period | Renewable Energy Share |
|---|---|
| 2020 | 21% |
| 2022 | 57% |
| Fiscal Year 2024 | 89% |
| Fiscal Year 2026 | 100% |
Today, the site sources 97% of its electricity requirement directly from solar and wind power through Open Access renewable energy agreements. The remaining 3% is balanced using International Renewable Energy Certificates (I-RECs), confirming that the entire consumption is supported by renewable sources.
Infrastructure and Broader Impact
The transition involved implementing long-term renewable power purchase agreements alongside direct investments in clean energy infrastructure, including a 2.7 MW wind project operating under a group captive model. Alongside these sources, Sai Life Sciences also implemented energy-efficiency initiatives, involving equipment upgrades, process optimization, and digital monitoring systems to reduce overall energy demand.The shift to clean energy extends across the organization. Currently, nearly 80% of Sai Life Sciences' total electricity consumption across its operations is sourced from renewable sources. As a direct result of these measures, the company has achieved zero market-based Scope 2 emissions, avoiding an estimated 35,110 metric tonnes of CO₂ emissions annually.
Sai Life Sciences, which provides full-service Contract Research, Development & Manufacturing Organization (CRDMO) services to global innovator pharma and biotech companies, stated that this Bidar milestone underscores the company's broader strategy of integrating scientific innovation, operational excellence, and sustainability into its growth trajectory.
SAILIFE Stock Price Movement
Today, Sai Life Sciences Limited shares edged higher, gaining 0.93% and settling at ₹1126.2. The stock maintained robust investor interest, closing on a volume of 634,223 shares while remaining close to its 52-week high of ₹1139.4.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.